FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022230966> ?p ?o ?g. }

• W2022230966 endingPage "627" @default.
• W2022230966 startingPage "617" @default.
• W2022230966 abstract "The carboxylic ionophore monensin was formulated into long-circulating nanoparticles with the help of polyethylene glycol/poly (DL-lactide-co-glycolide) diblock copolymers, in an attempt to enhance the cytotoxicity of a ricin-based immunotoxin, anti-My9, and anticancer drugs like adriamycin and tamoxifen. This study looked into various aspects involving the preparation (using a homogenizer and an EmulsiFlex homogenizer-extrusion device) and lyophilization of long-circulating monensin nanoparticles (LMNP) of particle size < 200 nm in diameter. The particle size of LMNP was reduced from 194 nm to 160 nm by passing the nanoparticles through an EmulsiFlex, before freeze-drying. There was a 4.8-83.7% increase in the particle size of LMNP after freeze-drying, which was dependent upon the manufacturing conditions such as use of the EmulsiFlex for size reduction before freeze-drying, the freezing method (rapid/slow) and the concentration of lyoprotectant (mannitol or trehalose) employed for freeze-drying. LMNP freeze-dried with 2.4% of trehalose showed minimal size change (< 9%) after freeze-drying. Further, the freezing method was found to have negligible effect on the particle size of LMNP freeze-dried with trehalose in comparison with mannitol. The entrapment efficiency of monensin in LMNP was found to be 14.2 +/- 0.3%. The LMNP were found to be spherical in shape and smooth in surface texture as observed by atomic force microscopy. In-vitro release of monensin from LMNP in phosphate buffered saline (PBS) pH 7.4 or PBS supplemented with 10% human serum indicated that there was an initial rapid release of about 40% in the first 8 h followed by a fairly slow release (about 20%) in the next 88 h. In-vivo studies conducted with Sprague-Dawley rats showed that 20% of monensin remained in circulation 4-8 h after the intravenous administration of LMNP. An in-vitro dye-based cytotoxicity assay (MTS/PMS method) showed that there was 500 times and 5 times potentiation of the cytotoxicity of anti-My9 immunotoxin by LMNP (5 x 10(-8) M of monensin) in HL-60 sensitive and resistant human tumour cell lines, respectively. Further, LMNP (5 x 10(-8) M of monensin) potentiated the cytotoxicity of adriamycin in MCF 7 and SW 620 cell lines by 100 fold and 10 fold, respectively, and that of tamoxifen by 44 fold in MCF 7 cell line as assessed by crystal violet dye uptake assay. Our results suggest that it is possible to prepare LMNP possessing appropriate particle size (< 200 nm), monensin content and in-vitro and in-vivo release characteristics with the help of a homogenizer and an EmulsiFlex homogenizer-extrusion device. LMNP can be freeze-dried with minimal increase in particle size by using a suitable concentration of a lyoprotectant like trehalose. Furthermore, LMNP could potentiate the cytotoxicity of immunotoxin, adriamycin and tamoxifen by 5-500 fold in-vitro, which will be further investigated in-vivo in a suitable animal model." @default.
• W2022230966 created "2016-06-24" @default.
• W2022230966 creator A5005969438 @default.
• W2022230966 creator A5015288866 @default.
• W2022230966 creator A5024023641 @default.
• W2022230966 creator A5055573986 @default.
• W2022230966 creator A5057434088 @default.
• W2022230966 creator A5061011964 @default.
• W2022230966 date "2001-05-01" @default.
• W2022230966 modified "2023-09-30" @default.
• W2022230966 title "Long-circulating monensin nanoparticles for the potentiation of immunotoxin and anticancer drugs" @default.
• W2022230966 cites W1556789333 @default.
• W2022230966 cites W1569531441 @default.
• W2022230966 cites W1607515676 @default.
• W2022230966 cites W1978550368 @default.
• W2022230966 cites W1990423985 @default.
• W2022230966 cites W1996785099 @default.
• W2022230966 cites W1998396545 @default.
• W2022230966 cites W2000076998 @default.
• W2022230966 cites W2012470334 @default.
• W2022230966 cites W202411787 @default.
• W2022230966 cites W2029749273 @default.
• W2022230966 cites W2030822319 @default.
• W2022230966 cites W2031332374 @default.
• W2022230966 cites W2058699400 @default.
• W2022230966 cites W2075050043 @default.
• W2022230966 cites W2075145223 @default.
• W2022230966 cites W2078816106 @default.
• W2022230966 cites W2086204355 @default.
• W2022230966 cites W2089854063 @default.
• W2022230966 cites W2109316426 @default.
• W2022230966 cites W2123299536 @default.
• W2022230966 cites W2129887903 @default.
• W2022230966 cites W2130277532 @default.
• W2022230966 cites W2157819234 @default.
• W2022230966 cites W2254092841 @default.
• W2022230966 cites W2316578626 @default.
• W2022230966 cites W53254058 @default.
• W2022230966 doi "https://doi.org/10.1211/0022357011775947" @default.
• W2022230966 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11370701" @default.
• W2022230966 hasPublicationYear "2001" @default.
• W2022230966 type Work @default.
• W2022230966 sameAs 2022230966 @default.
• W2022230966 citedByCount "26" @default.
• W2022230966 countsByYear W20222309662012 @default.
• W2022230966 countsByYear W20222309662013 @default.
• W2022230966 countsByYear W20222309662016 @default.
• W2022230966 countsByYear W20222309662017 @default.
• W2022230966 countsByYear W20222309662019 @default.
• W2022230966 countsByYear W20222309662020 @default.
• W2022230966 countsByYear W20222309662022 @default.
• W2022230966 countsByYear W20222309662023 @default.
• W2022230966 crossrefType "journal-article" @default.
• W2022230966 hasAuthorship W2022230966A5005969438 @default.
• W2022230966 hasAuthorship W2022230966A5015288866 @default.
• W2022230966 hasAuthorship W2022230966A5024023641 @default.
• W2022230966 hasAuthorship W2022230966A5055573986 @default.
• W2022230966 hasAuthorship W2022230966A5057434088 @default.
• W2022230966 hasAuthorship W2022230966A5061011964 @default.
• W2022230966 hasConcept C13965031 @default.
• W2022230966 hasConcept C147789679 @default.
• W2022230966 hasConcept C155672457 @default.
• W2022230966 hasConcept C171250308 @default.
• W2022230966 hasConcept C185592680 @default.
• W2022230966 hasConcept C187530423 @default.
• W2022230966 hasConcept C192562407 @default.
• W2022230966 hasConcept C192797455 @default.
• W2022230966 hasConcept C2778445172 @default.
• W2022230966 hasConcept C2778452849 @default.
• W2022230966 hasConcept C2780224938 @default.
• W2022230966 hasConcept C43617362 @default.
• W2022230966 hasConcept C55493867 @default.
• W2022230966 hasConcept C84199377 @default.
• W2022230966 hasConceptScore W2022230966C13965031 @default.
• W2022230966 hasConceptScore W2022230966C147789679 @default.
• W2022230966 hasConceptScore W2022230966C155672457 @default.
• W2022230966 hasConceptScore W2022230966C171250308 @default.
• W2022230966 hasConceptScore W2022230966C185592680 @default.
• W2022230966 hasConceptScore W2022230966C187530423 @default.
• W2022230966 hasConceptScore W2022230966C192562407 @default.
• W2022230966 hasConceptScore W2022230966C192797455 @default.
• W2022230966 hasConceptScore W2022230966C2778445172 @default.
• W2022230966 hasConceptScore W2022230966C2778452849 @default.
• W2022230966 hasConceptScore W2022230966C2780224938 @default.
• W2022230966 hasConceptScore W2022230966C43617362 @default.
• W2022230966 hasConceptScore W2022230966C55493867 @default.
• W2022230966 hasConceptScore W2022230966C84199377 @default.
• W2022230966 hasIssue "5" @default.
• W2022230966 hasLocation W20222309661 @default.
• W2022230966 hasLocation W20222309662 @default.
• W2022230966 hasOpenAccess W2022230966 @default.
• W2022230966 hasPrimaryLocation W20222309661 @default.
• W2022230966 hasRelatedWork W1991263563 @default.
• W2022230966 hasRelatedWork W2011111253 @default.
• W2022230966 hasRelatedWork W2017027704 @default.
• W2022230966 hasRelatedWork W2022230966 @default.
• W2022230966 hasRelatedWork W2351642351 @default.
• W2022230966 hasRelatedWork W2387583554 @default.

• next